Editorial board

Editor-in-Chief
Janice M. Reichert - The Antibody Society, Inc., Framingham, MA, USA  [email protected]   

Associate Editor
Alain Beck - Centre d'Immunologie Pierre Fabre, St Julien-en-Genevois, France
Alexey A Lugovskoy -  Diagonal Therapeutics, Cambridge, MA, USA 

Assistant Editors

Patrick Bulau - Roche Diagnostics GmbH, Penzberg, Germany
Partha S. Chowdhury – Janssen Biopharmaceutical, Spring House, PA, USA
Marc Damelin - Mersana Therapeutics, Cambridge, MA, USA
Nimish Gera - Mythic Therapeutics, Waltham, MA, USA
Nathan Higginson-Scott - Seismic Therapeutic, Cambridge, MA, USA
Nick Hutchinson - FUJIFILM Diosynth Biotechnologies, Billingham, UK
Konrad Krawczyk - Natural Antibody, Szczecin, Poland
Pin-Kuang Lai - Stevens Institute of Technology, Hoboken, New Jersey, USA
Sandeep Kumar - Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
Jonathan Sockolosky - Genentech, South San Francisco, CA, USA
Feng Yang - Genentech, South San Francisco, CA, USA
Honghui Zhou - Janssen Research & Development, LLC, Spring House, PA, USA
Li Zhou - AbbVie, Worcester, MA, USA
Zhaohui Sunny Zhou - Northeastern University, Boston, MA, USA

Editorial Board
Taruna Arora - Bristol Myers Squibb., Redwood City, CA, USA
Andrew Bradbury - Specifica Inc, Santa Fe, NM, USA
Pavel V. Bondarenko - Amgen, Thousand Oaks, CA, USA
Paul J. Carter - Genentech, Oceanside, CA USA
Steven Chamow - Alira Health Boston, LLC, Framingham, MA, USA
Daniel Christ - Garvan Institute of Medical Research, Syndey Australia
Stefan Dübel - Technische Universität Braunschweig, Braunschweig, Germany
Charles Dumontet - Université de Lyon, Lyon, France
William (Jonny) Finlay - UltraHuman Limited, Edinburgh, UK
Patrick Garidel - Boehringer Ingelheim Pharma GmbH & Co KG, Innovation Unit, Biberach, Germany
Iqbal S. Grewal - Janssen, Spring House, PA, USA
Hiten Gutka - Bristol Myers Squibb, New Brunswick, NJ, USA
Jagath Reddy Junutula - Aarvik Therapeutics, Fremonth, CA, USA
Christian Klein - Roche Glycart AG, pRED, Zürich, Switzerland
Roland E. Kontermann - Universität Stuttgart, Stuttgart, Germany
Marie-Paule Lefranc - Université Montpellier II, Montpellier, France
John McCafferty - Maxion Therapeutics, Cambridge, UK
Dario Neri - Swiss Federal Institute of Technology Zürich, Zürich, Switzerland
Paul Parren - LAVA Therapeutics, Utrecht, The Netherlands
Andreas Plückthun - University of Zürich, Zürich, Switzerland
E. Sally Ward - University of Southampton, Southampton, UK
Hervé Watier - Université François-Rabelais/CNRS, Tours, France
Jan van de Winkel - Genmab, Copenhagen, Denmark
K. Dane Wittrup - Massachusetts Institute of Technology, Cambridge, MA, USA
Clive Wood - Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany
Thierry Wurch - Evotec, Lyon, France
Jianlin (Jim) Xu - Bristol-Myers Squibb, Devens, MA, USA